Amneal Pharmaceuticals is a global biopharmaceutical company that has evolved from its origins as a generics manufacturer into a diversified healthcare organization. The company operates across complex generics, biosciences, and specialty medicines, and has a portfolio of over 290 pharmaceutical products. Founded in 2002, it maintains a presence in the United States, India, and Ireland.
Amneal's technical capabilities span pharmaceutical manufacturing, biosimilars development, and injectable medicine development. The company's founder-led culture traces its inspiration to the founder's father, an industrial pharmacist, with honesty and integrity cited as core values.
The firm manufactures its extensive product range to support the accessibility of essential medicines. Its operations extend across multiple industry verticals including biopharmaceuticals, healthcare, generics, biosciences, and specialty medicines.
